BioArctic: FDA approves IV maintenance dosing of Leqembi (lecanemab-irmb) for the treatment ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...
Hometown Source3 小时
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA ...
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent ...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
来自MSN8 小时
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
LAist1 天
DEI cancer initiative
About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...
Wausau Pilot and Review1 天
FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s ...
Look out for Red 3, FD&C Red No. 3, erythrosine or E127 in the ingredients list of your favorite processed foods. Anhelina ...
The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
JD Supra2 天
FDA Bans Red Dye No. 3 Under the Delaney Clause
The US Food and Drug Administration (FDA) has revoked its authorization for the use of FD&C Red No. 3, also known as Red Dye No. 3. Issued on ...
The American Journal of Managed Care2 天
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
FDA spars with Waco company over ‘unapproved’ and ‘unlicensed’ human amniotic products
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...